Dark Forest Capital Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Dark Forest Capital Management’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-60,216	Closed	-$766K	–	1176
2023 Q3	$766K	Buy	60,216 +9,553	+19%	+$132K	0.06%	531
2023 Q2	$713K	Buy	50,663 +49,772	+5,586%	+$712K	0.07%	461
2023 Q1	$13.8K	Buy	+891	New	+$14.9K	﹤0.01%	1004
2022 Q4	–	Sell	-2,858	Closed	-$53K	–	1567
2022 Q3	$53K	Buy	2,858 +2,856	+142,800%	+$44.8K	0.01%	513
2022 Q2	$0	Sell	2 -15	-88%	-$166	﹤0.01%	1490
2022 Q1	$0	Sell	17 -726	-98%	-$6.17K	﹤0.01%	1864
2021 Q4	$7K	Buy	+743	New	+$14K	﹤0.01%	1078

Other funds holding DCPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Dark Forest Capital Management's DCPH Position: Q4 2023 in Review

Dark Forest Capital Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q4 2023, closing a stake of 60,216 shares — an estimated $766K sold.

Dark Forest Capital Management first reported a position in DCPH in Q4 2021 and held it in 7 quarters. The position peaked at $766K in Q3 2023. 164 funds tracked by Wall St. Rank hold DCPH as of Q4 2023.

Dark Forest Capital Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Dark Forest Capital Management sold 60,216 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q4 2023, an estimated $766K.
Dark Forest Capital Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 7 quarters.
Dark Forest Capital Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $766K in Q3 2023.
164 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q4 2023.

Based on Dark Forest Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.